W.R. Berkley Corp’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History
Bought
Maintained
Sold
Other funds holding TDACW
MF
SCM
CL
AA
PAMP
LP
LA
W.R. Berkley Corp's TDACW Position: Q1 2026 in Review
W.R. Berkley Corp held its Translational Development Acquisition Corp Warrants (TDACW) position steady in Q1 2026 at 17,254 shares worth $2.42K. The position accounts for ﹤0.01% of the portfolio, ranked #344.
W.R. Berkley Corp first reported a position in TDACW in Q1 2025 and has held it in 5 quarters since. The position peaked at $20K in Q2 2025. 32 funds tracked by Wall St. Rank hold TDACW as of Q1 2026.
- W.R. Berkley Corp held 17,254 shares of Translational Development Acquisition Corp Warrants worth $2.42K as of Q1 2026.
- W.R. Berkley Corp left its Translational Development Acquisition Corp Warrants share count unchanged in Q1 2026.
- Translational Development Acquisition Corp Warrants made up ﹤0.01% of W.R. Berkley Corp's portfolio in Q1 2026, its #344 holding.
- W.R. Berkley Corp first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 5 quarters since.
- W.R. Berkley Corp's Translational Development Acquisition Corp Warrants position peaked at $20K in Q2 2025.
- 32 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q1 2026.
Based on W.R. Berkley Corp's 13F filing for Q1 2026, filed 15 May 2026.